Cite
HARVARD Citation
De Marco, D. et al. (2022). Vedolizumab-Associated Hypereosinophilia and Hepatoxicity. ACG Case Reports Journal. 9 (11), pp. e00905-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
De Marco, D. et al. (2022). Vedolizumab-Associated Hypereosinophilia and Hepatoxicity. ACG Case Reports Journal. 9 (11), pp. e00905-. [Online].